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Abstract—The liver is an immunocompetent organ that plays a key role in the immune response to
infections, and the development of hepatic immune function during early postnatal stages has not
been thoroughly characterized. This study analyzed the constitutive expression of complement fa-
ctors, namely C3 and C9, and pattern recognition receptors, namely CD14, toll-like receptor (TLR)-
4, and lipopolysaccharide binding protein (LBP), in the liver of postnatal day (P)1, P21, and P70
rats, and compared the kinetics of induction of cytokines and chemokines in the liver of P 1 and P
21 animals. Our studies found that while the mRNA expression of C3, C9, CD14, and TLR-4 was
lower in P1 animals, the mRNA level of LBP was higher in P1 animals as compared to older
animals, and that the kinetics of induction of cytokines and chemokines was signiﬁcantly delayed in
P1 as compared to P21 liver following LPS stimulation. Our data suggest that hepatic innate im-
munity is deﬁcient in the neonates and undergo signiﬁcant development during early postnatal life.
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INTRODUCTION
Bacterial infection can lead to sepsis which may
result in multiple organ failure or even mortality. Lip-
opolysaccharide (LPS), a complex glycolipid component
of the cell wall of Gram-negative bacteria, is a potent
activator of the innate immune response and a major
cause of septic shock [1]. LPS is recognized by pattern
recognition receptors (PRRs) such as LPS binding protein
(LBP), CD14, and toll-like receptor (TLR)-4. The bind-
ing of LPS to TLR-4/myeloid differentiation protein
(MD)-2 complex initiates an intracellular signaling net-
work, eventually leading to increased expression of many
inﬂammatory cytokines, such as tumor necrosis factor
(TNF)-α, interleukin (IL)-1β, and IL-6, and chemokines,
such as macrophage inﬂammatory protein (MIP)-1β,
MIP-2, monocyte chemotactic protein (MCP)-1, and
keratinocyte-derived chemokine (KC) [2, 3].
Newborns are known to be more susceptible to
infections by many microbes than adults. Many studies
have suggested that the differences in their immune
function may be the main contributing factors. For
example, the polymorphonuclear leukocytes (PMNs)
from preterm infants exhibit a much reduced antibacte-
rial activity than those from adults, paralleled by a much
lower level of CD14 expression [4]. Neonatal monocytes
secrete a much reduced level of TNF-α than adult
human peripheral blood monocytes (PBMCs) following
LPS stimulation [5, 6]. Neonatal mice also have
increased susceptibility and mortality to sepsis associ-
ated with an attenuated inﬂammatory response as
compared to adults [7–9]. Taken together, these studies
indicate a functional immaturity of the immune system
at birth in the neonates.
As the largest solid organ in the body, liver receives
80% of its blood supply from the gut through the portal
vein that is rich in bacterial products and environmental
toxins, and functions as a major ﬁlter organ [10, 11].
Furthermore, liver is considered to be of major impor-
tance in innate immunity function, contributing to
antiviral, antibacterial, and antitumor defenses [11, 12].
The liver consists of parenchymal hepatocytes and
nonparenchymal cells, such as sinusoidal endothelial
cells, Kupffer cells, and hepatic stellate cells [13]. Both
parenchymal and non-parenchymal cells express CD14
and TLR-4, and can respond to LPS stimulation
characterized by increased expression of inﬂammatory
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576cytokines and chemokines [14–17]. Liver also contrib-
utes to systemic innate immunity through the biosyn-
thesis of acute phase proteins such as LBP which is also
a PRR and complement components such as C3 and C9
[11].
In this study, we aimed at investigating the
postnatal development of hepatic innate immunity. We
examined the constitutive expression of key innate
immune mediators, speciﬁcally complement factors and
PRRs during postnatal development, and compared the
induction kinetics of cytokines and chemokines in the
liver of postnatal day (P)1 and P21 animals following
LPS treatment.
MATERIALS AND METHODS
Animals
Young adult male and female Sprague–Dawley®
rats were purchased from Harlan Inc. (Indianapolis, IN,
USA), maintained in a temperature- and humidity-
controlled facility with a 12-h light/dark cycle, and fed
with water and a standard rat diet ad libitum. The
animals were given at least 1 week to acclimate to the
animal facility before beginning the experiments. Ani-
mal studies were conducted with the approval from the
Institutional Animal Care and Use Committee at Seton
Hall University. The male rats were housed together
with female rats for breeding, and the female rats with
vaginal plugs were moved to separate cages under
above-mentioned conditions [18]. For time-course stud-
ies, P1 or P21 pups were treated with 0.25 mg/kg LPS
for 0 h, 0.5 h, 1 h, 2 h, 6 h, or 24 h via i.p. injection (four
pups per group). At the end of treatment, the animals
were sacriﬁced and their liver tissues were dissected to
extract total RNA.
Total RNA Extraction
Total RNA from the dissected liver tissues was
isolated using the TRIzol reagent (Invitrogen, Grand
Island, NY, USA) according to manufacturer’s instruc-
tions, dissolved in RNase-free water, and stored at
−80°C.
Semi-Quantitative Reverse Transcriptase–
Polymerase Chain Reaction (RT–PCR) Assay
After cDNA synthesis, PCR ampliﬁcation was
conducted using appropriate sense and antisense primers
speciﬁc for rat β-actin (a housekeeping gene), IL-1β,
IL-6, TNF-α, KC, MIP-1β, MCP-1, MIP-2, TLR-4,
CD14, MD-2, LBP, C3, and C9 [18, 19]. The sense and
antisense primers for rat MD-2 were: 5′-GTG-GAT-
CTG-CAA-CTC-CTC-CGA-TGC-3′ and 5′-TGC-TGT-
GTT-GAC-AGC-CTC-CCC-T-3′, respectively; the sense
and antisense primers for rat MCP-1 were: 5′-ATG-ATC-
CCA-ATG-AGT-CGG-3′ and 5′-ACA-GAA-GTG-CTT-
GAG-GTG-3′, respectively; the sense and antisense
primers for rat LBP were: 5′-CCG-GGT-TTA-CCA-
CCA-GGC-CG-3′ and 5′-TTC-GTG-ACC-ACG-CCA-
AGC-CG-3′, respectively; the sense and antisense
primers for rat C3 were: 5′-GGG-ACC-CCG-GTG-
GCT-CAG-AT-3′ and 5′-GCT-GTC-AGC-CAG-GTG-
CTG-GG-3′, respectively; and the sense and antisense
primers for rat C9 were: 5′-TGC-CGT-GAC-CGG-GTG-
GTA-GAA-3′ and 5′-TGT-CAG-CCT-TGG-TTT-CAT-
AGG-CCA-GA-3′, respectively. The PCR reactions
were carried out by heating the samples to 94°C for
5 min, followed by appropriate cycles of denaturation at
94°C for 30 s, annealing at 57°C for 30 s, and extension
at 72°C for 30 s. After the ﬁnal cycle, the PCR reactions
were extended for another 7 min. The optimum number
of cycles were 25 cycles for C3 and LBP; 26 cycles for
TNF-α and CD14; 27 cycles for IL-1β; 28 cycles for IL-
6, KC, and MCP-1; 29 cycles for C9, MIP-1β, and MD-
2; 30 cycles for TLR-4 and MIP-2; and 21 cycles for β-
actin. After running PCR products on a 2.0% agarose
gel, the gel image was recorded using a UVP GelDoc-
It™ imaging system (UVP, Upland, CA, USA) and
digitized using VisionWorks™ LS software (UVP). The
relative intensities for the genes of interest were
normalized to the intensity of β-actin in the same
sample.
Statistical Analysis
All data were analyzed using one-way analysis of
variance (ANOVA) followed by Newman–Keuls post-
test (GraphPad Prizm, La Jolla, CA, USA) and presented
as means±SE. Results with p<0.05 were considered
statistically signiﬁcant.
RESULTS
Constitutive Hepatic Expression of Acute Phase
Proteins During Postnatal Development
Liver is critical for producing important acute phase
immune mediators such as complement components
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Fig. 1. Basal mRNA expression levels of C3 (a, b), C9 (a, c), and LBP (a, d) in the liver of P1, P21, and P70 animals. a Representative RT–PCR of
C3, C9, LBP, and β-actin. b Quantitation of RT–PCR of C3 normalized to β-actin. c Quantitation of RT–PCR of C9 normalized to β-actin. d
Quantitation of RT–PCR of LBP normalized to β-actin. Data were presented as means±SE; n=4. Asterisk represents signiﬁcant difference from P1
group at p<0.05 (one-way ANOVA followed by Newman–Keuls post-test).
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Fig. 2. Basal mRNA expression levels of TLR-4 (a, b), MD-2 (a, c), and CD14 (a, d) in the liver of P1, P21, and P70 animals. a Representative RT–
PCR of TLR-4, MD-2, CD14, and β-actin. b Quantitation of RT–PCR of TLR-4 normalized to β-actin. c Quantitation of RT–PCR of MD-2
normalized to β-actin. d Quantitation of RT–PCR of CD14 normalized to β-actin. Data were presented as means±SE; n=4. Asterisk represents
signiﬁcant difference from P1 group at p<0.05 (one-way ANOVA followed by Newman–Keuls post-test).
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levels of C3 and C9 in the liver of P1, P21, and P70
animals. The mRNA levels of C3 and C9 in the liver of
P1 were signiﬁcantly lower than that in P21 and P70.
While the mRNA level of C3 in P21 liver was
comparable to that in P70 liver, the mRNA level of C9
in P21 liver was signiﬁcantly lower than that in P70 liver
(Fig. 1b, c). In contrast, the expression of another acute
phase protein LBP, also a soluble pattern recognition
receptor for LPS, was higher in P1 liver and gradually
decreased during postnatal development (Fig. 1d).
Constitutive Hepatic Expression of PRRs
During Postnatal Development
LPS is recognized by PRRs such as LBP and
CD14, which then transfers LPS to TLR-4/MD-2
complex to initiate the intracellular signaling network
[2, 3]. We therefore examined the constitutive expres-
sion of these upstream mediators of LPS-initiated
signaling pathway, namely TLR-4, MD-2, and CD14,
in the liver of P1, P21, and P70 animals. While MD-2
mRNA was not signiﬁcantly altered in P1, P21, and P70
liver (Fig. 2c), the mRNA levels of TLR-4 (Fig. 2b) and
CD14 (Fig. 2d) were lower in P1 liver and increased
during postnatal development.
Kinetics of Induction of Pro-inﬂammatory Cytokines
in the Liver of P1 Animals
Pro-inﬂammatory cytokines play key roles in the
inﬂammatory process [20], therefore, we examined the
kinetics of induction of pro-inﬂammatory cytokines,
namely TNF-α, IL-1β, and IL-6, in the liver of P1
animals following LPS treatment. In the liver of P1
animals, the mRNA levels of TNF-α (Fig. 3b) and IL-
1β (Fig. 3c) were signiﬁcantly elevated by 2 h, remained
elevated at 6 h, and signiﬁcantly decreased by 24 h
following LPS stimulation, and the mRNA level of IL-6
was signiﬁcantly increased at 6 h and declined to basal
level by 24 h following LPS treatment (Fig. 3d).
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Fig. 3. Time course of TNF-α (a, b), IL-1β (a, c), and IL-6 (a, d) expression in the liver of P1 animals at 0 h, 0.5 h, 1 h, 2 h, 6 h, and 24 h following
LPS stimulation. a Representative RT–PCR of TNF-α, IL-1β, IL-6, and β-actin. b Quantitation of RT–PCR of TNF-α normalized to β-actin. c
Quantitation of RT–PCR of IL-1β normalized to β-actin. d Quantitation of RT–PCR of IL-6 normalized to β-actin. Data were presented as means±
SE; n=4. Asterisk represents signiﬁcant difference from 0 h group at p<0.05 (one-way ANOVA followed by Newman–Keuls post-test).
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in the Liver of P21 Animals
We then examined the kinetics of induction of
TNF-α,I L - 1 β, and IL-6 in the liver of P21 animals
following LPS treatment. The mRNA level of TNF-α
(Fig. 4b) was signiﬁcantly elevated by 0.5 h, peaked
at 1 h, started to decline by 6 h, and returned to
basal level following LPS stimulation; the mRNA
level of IL-1β (Fig. 4c)w a ss i g n i ﬁcantly elevated by
0.5 h, peaked at 2 h, started to decline by 6 h, and
returned to basal level by 24 h following LPS
stimulation; and the mRNA level of IL-6 (Fig. 4d)
was signiﬁcantly elevated by 1 h, peaked at 2 h, and
returned to basal level by 6 h following LPS
stimulation. These data suggest that the kinetics of
LPS-induced expression of pro-inﬂammatory cyto-
kines in the liver of P1 animals was generally delayed as
compared to that in the liver of P21 animals.
Kinetics of Induction of Anti-inﬂammatory Cytokine
in the Liver of P1 and P21 Animals
Anti-inﬂammatory cytokines play key roles in
quenching the inﬂammatory response [20]; therefore,
we examined the kinetics of induction of IL10, an
anti-inﬂammatory cytokine, in the liver of P1 and
P21 animals following LPS treatment. The mRNA
level of IL-10 was signiﬁcantly increased at 2 h,
started to decrease by 6 h, and returned to basal level
by 24 h following LPS stimulation in the liver of P1
animals (Fig. 5a). In contrast, the mRNA level of IL-10
was signiﬁcantly increased at 0.5 h, remained elevated
through 6 h, and returned to basal level by 24 h following
LPS stimulation in the liver of P21 animals (Fig. 5b).
These data suggest that the kinetics of LPS-induced
expression of IL-10 in the liver of P1 animals was
also delayed as compared to that in the liver of P21
animals.
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Fig. 4. Time course of TNF-α (a, b), IL-1β (a, c), and IL-6 (a, d) expression in the liver of P21 animals at 0 h, 0.5 h, 1 h, 2 h, 6 h, and 24 h following
LPS stimulation. a Representative RT–PCR of TNF-α, IL-1β, IL-6, and β-actin. b Quantitation of RT–PCR of TNF-α normalized to β-actin. c
Quantitation of RT–PCR of IL-1β normalized to β-actin. d Quantitation of RT–PCR of IL-6 normalized to β-actin. Data were presented as means±
SE; n=4. Asterisk represents signiﬁcant difference from 0 h group at p<0.05 (one-way ANOVA followed by Newman–Keuls post-test).
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Fig. 5. Time course of IL-10 expression in the liver of P1 (a) and P21 (b) animals at 0 h, 0.5 h, 1 h, 2 h, 6 h, and 24 h following LPS stimulation.
Quantitation of IL-10 was normalized to β-actin. Data were presented as means±SE; n=4.Asterisk represents signiﬁcant difference from 0 h group at
p<0.05 (one-way ANOVA followed by Newman–Keuls post-test).
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Fig. 6. Time course of MIP-2 (a), MIP-1β (b), MCP-1 (c), and KC (d) expression in the liver of P1 animals at 0 h, 0.5 h, 1 h, 2 h, 6 h, and 24 h
following LPS stimulation. Quantitation of RT–PCR of these chemokines was normalized to β-actin. Data were presented as means±SE; n=4.
Asterisk represents signiﬁcant difference from 0 h group at p<0.05 (one-way ANOVA followed by Newman–Keuls post-test).
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of P1 Animals
We then examined LPS-induced expression of
chemokines, namely MIP-1β, MIP-2, MCP-1, and KC,
in the liver of P1 animals. In the liver of P1 animals, the
mRNA levels of MIP-1β (Fig. 6b) and MCP-1 (Fig. 6c)
were signiﬁcantly elevated at 6 h and started to decrease
by 24 h following LPS stimulation; and the mRNA
levels of MIP-2 (Fig. 6a) and KC (Fig. 6d)w e r e
signiﬁcantly elevated at 2 h, peaked at 6 h, and returned
to basal level by 24 h following LPS stimulation.
Kinetics of Induction of Chemokines in the Liver
of P21 Animals
We then examined LPS-induced expression of
MIP-1β, MIP-2, MCP-1, and KC in the liver of P21
animals. The mRNA level of MIP-2 (Fig. 7a) was
signiﬁcantly elevated at 0.5 h, continued to increase at
1 h, remained high at 2 h, and returned to basal level by
6 h following LPS stimulation; and the mRNA levels of
MIP-1β (Fig. 7b), MCP-1 (Fig. 7c), and KC (Fig. 7d)
were signiﬁcantly elevated at 0.5 h, peaked at 2 h,
started to decline by 6 h, and returned to basal level by
24 h following LPS stimulation. These data suggest that
the kinetics of LPS-induced expression of chemokines in
the liver of P1 animals was generally delayed as
compared to that in the liver of P21 animals.
DISCUSSION
During early postnatal period, liver undergoes
functional maturation from a major hematopoietic tissue
to a central organ for intermediary metabolism with
important exocrine, endocrine, and innate immune
functions [21, 22]. Shortly after birth, neonatal liver
must have the capacity to deal with bacteria derived
from the intestinal tract besides a range of hormones,
food antigens, and complex molecules as colonies of
bacteria start to establish themselves in the intestine and
develop a stable microﬂora in the large bowel [23]. The
innate immune response is the ﬁrst line of defense
against a diverse range of microbes, and the liver
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Fig. 7. Time course of MIP-2 (a), MIP-1β (b), MCP-1 (c), and KC (d) expression in the liver of P21 animals at 0 h, 0.5 h, 1 h, 2 h, 6 h, and 24 h
following LPS stimulation. Quantitation of RT–PCR of these chemokines was normalized to β-actin. Data were presented as means±SE; n=4.
Asterisk represents signiﬁcant difference from 0 h group at p<0.05 (one-way ANOVA followed by Newman–Keuls post-test).
582 Le Rouzic, Corona, and Zhouproduces important innate immune mediators such as
acute phase proteins, complement factors, cytokines, and
chemokines [13]. Therefore, we delineated the age-
dependent maturation of hepatic innate immunity in this
study. We found that the mRNA levels of C3 and C9 in
P1 liver were signiﬁcantly reduced compared to P21 and
P70 liver, which may contribute to impaired opsoniza-
tion potential in the neonates. We also found that the
kinetics of the induction of cytokines and chemokines in
P1 liver was signiﬁcantly delayed as compared to P21
liver. These data suggest that the initial hepatic inﬂam-
matory response in the neonates may not be sufﬁcient to
combat bacterial infections. Consistently, some prema-
ture newborn infants that are affected by hyperacute
fulminant pneumonia due to Gram-positive (Group B
Streptococcus, in particular) or Gram-negative (Escher-
ichia coli and others) bacteria are actually found to be
deﬁcient in their initial acute phase response [24].
There is increasing evidence that the decreased
level of CD14 and the elevated level of LBP may
account for the delayed induction of cytokines and
chemokines in P1 liver. CD14 and LBP are known to
play key roles in promoting innate immunity to Gram-
negative bacteria by transferring LPS to TLR4/MD-2
receptor signaling complex. LBP has been suggested to
play a biphasic role by enhancing the response to LPS at
low concentration and inhibiting LPS response at high
concentration [25, 26]. Consistently, LBP treatment has
been reported to suppress LPS-induced IL-1β expres-
sion by human gingival ﬁbroblasts [27]. It is likely that
the elevated level of LBP in P1 liver may suppress the
hepatic response to LPS. Furthermore, it has been
reported that LPS-induced TLR-4/MD-2 dimerization
occurs only in membrane-associated CD14-expressing
cells and that this dimerization prompts rapid signaling
during innate immune responses [28]. Therefore, lower
CD14 expression may lead to lower TLR-4/MD-2
complex formation and therefore delayed innate immune
signaling in P1 liver. Additionally, diminished TLR-4
mRNA level in P1 liver may also contribute to lower
TLR-4/MD-2 complex formation, thereby delaying
TLR-4-mediated response to LPS.
In summary, our studies showed that the mRNA
expression of C3, C9, CD14, and TLR-4 was lower in
P1 liver and the mRNA level of LBP was higher in P1
liver as compared to older animals. We also found that
the kinetics of induction of cytokines and chemokines
was signiﬁcantly delayed in P1 liver as compared to P21
liver following LPS stimulation. The decreased produc-
tion of complement components and delayed TLR-4
response in neonatal rats may protect the host from
inﬂammation but may also leave them more susceptible
to local hepatic and systemic infections. Insight into the
kinetics of induction of inﬂammatory mediators in the
neonates may help in designing new strategies to
modulate the maturation of their innate immune system,
and to prevent and/or treat infections during this
vulnerable period.
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